<DOC>
	<DOCNO>NCT00269893</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness safety abciximab ( anti-platelet therapy ) versus placebo patient undergoing high risk coronary angioplasty .</brief_summary>
	<brief_title>A Study Evaluating Efficacy Safety Abciximab , Anti-platelet Therapy , Patients Undergoing High-risk Coronary Angioplasty</brief_title>
	<detailed_description>This randomize , double-blind , placebo-controlled , multicenter study evaluate efficacy safety abciximab , anti-platelet therapy , patient undergo high risk coronary angioplasty . The primary outcome study include follow : number death cause , myocardial infarction recurrent ischemic event require urgent intervention ( e.g. , repeat angioplasty , coronary artery bypass surgery , intracoronary stent placement , intra-aortic balloon pump ) . Patients receive abciximab bolus , abciximab bolus plus infusion , placebo .</detailed_description>
	<mesh_term>Angina , Unstable</mesh_term>
	<mesh_term>Abciximab</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<mesh_term>Immunoglobulin Fab Fragments</mesh_term>
	<criteria>Patients refer elective urgent coronary balloon angioplasty atherectomy FDAapproved device one follow setting : unstable angina nonQ wave myocardial infarction , acute Qwave myocardial infarction , highrisk clinical/morphological characteristic Patients history hemorrhagic diathesis Having major surgery clinically significant gastrointestinal genitourinary bleeding within 6 week study enrollment Having stroke within 2 year prior enrollment stroke significant residual neurological deficit Having occlusion leave main coronary artery great 50 % history vasculitis Treated oral anticoagulant within 7 day ( unless prothrombin time = &lt; 1.2 time control ) intravenous dextran ( plan treatment angioplasty )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Abciximab</keyword>
	<keyword>Angina , unstable</keyword>
	<keyword>Angioplasty , transluminal , Percutaneous coronary</keyword>
</DOC>